FDA Drug Recalls

Recalls / Class II

Class IID-1170-2016

Product

B-COMPLEX WITHOUT B12 (PF) IN NACL 0.9%, B1-100MG, B2-5-PO4-2MG, B3-50MG, B5-2MG, B6-2MG/ML, In a) 2ML Vials and b) 5ML Vials, MEDAUS PHARMACY

Affected lot / code info
a) Lot #: 151130-66, BUD: 05/28/16; Lot #: 160222-51, BUD: 08/20/16. b) Lot #: 151130-60, BUD: 05/28/16; Lot #: 160222-51, BUD: 08/20/16.

Why it was recalled

Lack of Assurance of Sterility

Recalling firm

Firm
Medaus, Inc.
Notification channel
E-Mail
Type
Voluntary: Firm initiated
Address
6801 Cahaba Valley Rd Ste 116, Birmingham, Alabama 35242-9609

Distribution

Quantity
4000 mL in Vials
Distribution pattern
U.S. Nationwide, Japan, and New Zealand.

Timeline

Recall initiated
2016-05-13
FDA classified
2016-07-08
Posted by FDA
2016-07-20
Terminated
2017-06-16
Status
Terminated

Source: openFDA Drug Enforcement endpoint. Recall record D-1170-2016. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.